Hammer’s “March Of dollars” Starts Collecting Money; Four Year Campaign Kicks Off Oct 12
In Brief: Chabner Says He ”Has No Intention Of Leaving NCI; “Yarbro Named Clinical Indicators Chairman
PRI’s Frederick Fee $903,866 For First Six Months Of New Contract
NCI To Implement Recommendations, Sondik Says
More Minorities, Women, Fewer MD On Study Sections
M.D. Anderson, Madrid In Joint Program
Straus asks to “Set Record Straight”
Cancer Letter Skips Next Two Weeks
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Johnson and Johnson reaches $5.5B settlement deal over talc lawsuits
- What happened at FDA? Replimune approval raises questions
- I grew up unhoused. Now, with support from ACS, I am an MD-PhD student focused on oncology
My mother instilled in me: “Never become a product of your circumstances.” - Duke Officials Silenced Med Student Who Reported Trouble in Anil Potti’s Lab
- FDA grants Replimune’s RP1 an accelerated approval on third submission after 10:3 vote from advisory committee
Amid political outcry, advisors accept weak data and give sponsor a chance to complete phase III trial









